To Be Discontinued Tablet Pulmonary/Allergy
Zileuton Tablet · 528 days since initial FDA posting
Brand: ZYFLO
FDA lists Zileuton Tablet as To Be Discontinued (Chiesi USA, Inc.).
No availability text on this FDA row.
Zileuton Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Zileuton Tablet
- Manufacturer
- Chiesi USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Zyflo, Tablet, 600 mg (NDC 10122-901-12)
- Package NDC
- 10122-901-12
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Apr 1, 2025
- Last Updated
- Apr 1, 2025
- Therapeutic Category
- Pulmonary/Allergy
Row fields from the FDA Drug Shortages database via openFDA.